Skip to content
10-Q

Quarterly Report

AEOLUS PHARMACEUTICALS, INC.

0001102624-15-001314

← back to feed
Filed
Aug 14, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Aug 11, 2015 135.93M sh
Stockholders Equity Q3 2015 · Jun 30, 2015 −$289K
Stockholders Equity Q3 2015 · Sep 30, 2014 $1.59M
Current Liabilities Q3 2015 · Jun 30, 2015 $1.49M
Current Liabilities Q3 2015 · Sep 30, 2014 $2M
Total Liabilities Q3 2015 · Jun 30, 2015 $1.49M
Total Liabilities Q3 2015 · Sep 30, 2014 $2M
Current Assets Q3 2015 · Jun 30, 2015 $1.17M
Current Assets Q3 2015 · Sep 30, 2014 $3.55M
Total Assets Q3 2015 · Jun 30, 2015 $1.21M
Total Assets Q3 2015 · Sep 30, 2014 $3.58M
Shares Diluted Q3 2015 · Jun 30, 2014 136.86K sh
Shares Diluted Q3 2015 · Jun 30, 2014 136.83K sh
Operating Cash Flow Q3 2015 · Jun 30, 2014 $403K
Cash And Equivalents Q3 2015 · Jun 30, 2014 $1.27M
Cash And Equivalents Q3 2015 · Sep 30, 2013 $869K
Eps Diluted Q3 2015 · Jun 30, 2014 $0.01
Eps Diluted Q3 2015 · Jun 30, 2014 $0.00
Eps Basic Q3 2015 · Jun 30, 2014 $0.01
Eps Basic Q3 2015 · Jun 30, 2014 $0.00
Sga Expense Q3 2015 · Jun 30, 2014 $577K
Sga Expense Q3 2015 · Jun 30, 2014 $2.06M
Rd Expense Q3 2015 · Jun 30, 2014 $2.83M
Rd Expense Q3 2015 · Jun 30, 2014 $4.71M
Net Income Q3 2015 · Jun 30, 2014 $1.58M
Net Income Q3 2015 · Jun 30, 2014 $445K
Operating Income Q3 2015 · Jun 30, 2014 $1.58M
Operating Income Q3 2015 · Jun 30, 2014 $445K